共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | NORGESIC |
| 申请号 | 013416 | 产品号 | 003 |
| 活性成分 | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 385MG;30MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 1982/10/27 | 申请机构 | MEDICIS PHARMACEUTICAL CORP
|
| 2 | 药品名称 | NORGESIC FORTE |
| 申请号 | 013416 | 产品号 | 004 |
| 活性成分 | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 770MG;60MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 1982/10/27 | 申请机构 | MEDICIS PHARMACEUTICAL CORP
|